Cover Image

<it>In vitro</it> effects of etanercept on the development of different T cell subsets in patients with juvenile idiopathic arthritis

Saved in:

Bibliographic Details
Main Authors:	Liotta Francesco (Author), Querci Valentina (Author), Capone Manuela (Author), Santarlasci Veronica (Author), Pagnini Ilaria (Author), Giani Teresa (Author), Simonini Gabriele (Author), Maggi Laura (Author), Cosmi Lorenzo (Author), Cimaz Rolando (Author), Maggi Enrico (Author), Annunziato Francesco (Author)
Format:	Book
Published:	BMC, 2011-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Influence of Overweight and Obesity on Treatment Response in Juvenile Idiopathic Arthritis
by: Teresa Giani, et al.
Published: (2019)

Usefulness of MRI in the follow-up of ERA-related sacroiliitis, and effectiveness of treatment with sulphasalazine
by: Pagnini Ilaria, et al.
Published: (2011)

Elbow monoarthritis: an atypical onset of juvenile idiopathic arthritis Elbow monoarthritis: an atypical juvenile idiopathic arthritis onset
by: G. Simonini, et al.
Published: (2012)

Cutaneous PAN and Common Variable Immunodeficiency: what causes what?
by: Azzari Chiara, et al.
Published: (2011)

Juvenile idiopathic arthritis in Harlequin ichthyosis, a rare combination or the clinical spectrum of the disease? Report of a child treated with etanercept and review of the literature
by: Francesco Baldo, et al.
Published: (2021)

Correction to: Juvenile idiopathic arthritis in Harlequin ichthyosis, a rare combination or the clinical spectrum of the disease? Report of a child treated with etanercept and review of the literature
by: Francesco Baldo, et al.
Published: (2021)

Etanercept in juvenile idiopathic arthritis: Who will benefit?
by: van den Berg JM, et al.
Published: (2011)

Efficacy and safety of Etanercept therapy in juvenile idiopathic arthritis
by: Shantere Ruta, et al.
Published: (2011)

USE OF ETANERCEPT IN PATIENTS WITH OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
by: Т. М. Bzarova, et al.
Published: (2014)

EFFICACY OF ETANERCEPT IN TREATMENT OF VARIOUS TYPES OF JUVENILE IDIOPATHIC ARTHRITIS
by: O. Yu. Konopel'ko, et al.
Published: (2013)

Increased percentages of calprotectin and TNF-Α double-positive monocytes in the acute phase of Kawasaki disease
by: Dieli Francesco, et al.
Published: (2011)

Evaluation of Efficacy and Safety of Etanercept and Etanercept + Methotrexate Therapy in Patients with Juvenile Idiopathic Arthritis without Systemic Manifestations
by: T. M. Bzarova, et al.
Published: (2016)

Discontinuation of etanercept after clinical remission in patients with juvenile idiopathic arthritis
by: Cohen Jean-David, et al.
Published: (2012)

Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept
by: Anders Öman, et al.
Published: (2021)

ASSESSMENT OF THE QUALITY OF LIFE OF PATIENTS WITH THE JUVENILE IDIOPATHIC ARTHRITIS TREATED BY THE ETANERCEPT
by: A. N. Fetisova, et al.
Published: (2014)

The efficacy and safety profile of biologic therapy with etanercept in juvenile idiopathic arthritis
by: Siamopoulou-Mavridou A, et al.
Published: (2011)

Etanercept discontinuation in a cohort of juvenile idiopathic arthritis patients: etanercept inefficacy but not intolerance is associated with oral corticosteroid use
by: Southwood TR, et al.
Published: (2008)

Serum amyloid A circulating levels and disease activity in patients with juvenile idiopathic arthritis
by: Mauro Galeazzi, et al.
Published: (2011)

No benefit of the combination therapy etanercept and methotrexate compared to etanercept mono therapy in juvenile idiopathic arthritis - a matched pair analysis
by: Schmeling Heinrike, et al.
Published: (2012)

Dynamics of concomitant therapy in children with juvenile idiopathic arthritis treated with etanercept and methotrexate
by: Ekaterina Alexeeva, et al.
Published: (2019)

Recurrent Pericarditis in Children and Adolescents
by: Enrico Tombetti, et al.
Published: (2019)

Etanercept improves pro-atherosclerotic biomarkers in children with juvenile idiopatic arthritis
by: Francesco Chiarelli, et al.
Published: (2011)

When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritis
by: Prince FHM, et al.
Published: (2008)

The impact of a 2-year Etanercept administration on growth of patients with juvenile idiopathic arthritis
by: Kaitalidou E, et al.
Published: (2011)

Safety and efficacy of biologic immunosuppressive treatment in juvenile idiopathic arthritis associated with inborn errors of immunity
by: V. Accardo, et al.
Published: (2024)

Early Prediction of Clinical Response to Etanercept Treatment in Juvenile Idiopathic Arthritis Using Machine Learning
by: Xiaolan Mo, et al.
Published: (2020)

Etanercept for patients with juvenile idiopathic arthritis: drug levels and influence of concomitant methotrexate: observational study
by: Tiina Levälampi, et al.
Published: (2023)

An in-depth analysis of young people's experience of their juvenile idiopathic arthritis (JIA) once receiving Etanercept
by: Livermore P, et al.
Published: (2008)

Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry
by: Timothy Beukelman, et al.
Published: (2021)

Multicentric Castleman's Disease (CD) in juvenile idiopathic arthritis (JIA) treated with etanercept: coincidence or causal relationship?
by: Rossi L, et al.
Published: (2008)

LONG TERM FOLLOW-UP ON EFFECTIVENESS AND SAFETY OF ETANERCEPT IN JUVENILE IDIOPATHIC ARTHRITIS WITHOUT SYSTEMIC MANIFESTATIONS
by: A. A. Baranov, et al.
Published: (2015)

The effect of etanercept therapy on adrenal steroid metabolism in juvenile idiopathic arthritis: a steroid metabolomics approach
by: Yonatan Butbul Aviel, et al.
Published: (2023)

Improvement of DAS-28 ESR score in Egyptian children and adolescents with juvenile idiopathic arthritis treated with etanercept
by: Rasha Abdel-Raouf Afifi, et al.
Published: (2017)

Bone mineral density improvement after one year of treatment with etanercept in patients with juvenile idiopathic arthritis
by: Susic G, et al.
Published: (2008)

Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting
by: Giovanna Ferrara, et al.
Published: (2018)

Evaluation of Efficacy and Safety of Etanercept Therapy in Patients with Early and Late Juvenile Idiopathic Arthritis without Systemic Manifestations
by: T. M. Bzarova, et al.
Published: (2015)

Septic Arthritis and Related Conditions
by: Teresa Giani, et al.
Published: (2022)

Reduction in the utilization of prednisone or methotrexate in Canadian claims data following initiation of etanercept in pediatric patients with juvenile idiopathic arthritis
by: Majed Khraishi, et al.
Published: (2019)

Case Report: Infantile Ischemic Stroke and Antiphospholipid Antibodies, Description of Four Cases
by: Teresa Giani, et al.
Published: (2020)

Experience of etanercept treatment in juvenile ankylosing spondyloarthritis
by: A. N. Fetisova, et al.
Published: (2013)